Uses
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Source: US FDA prescribing information
Molecule
Betamethasone valerate is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream, foam and ointment for topical use. MedsAcross supplies Betamethasone valerate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Source: US FDA prescribing information
Apply a thin film of Betamethasone Valerate Cream or Ointment to the affected skin areas one to three times a day. Dosage once or twice a day is often effective.
Source: US FDA prescribing information
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Source: US FDA prescribing information
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.
Source: US FDA prescribing information
Store at room temperature 15°-30°C (59°-86°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
6 presentations of Betamethasone valerate, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Betamethasone valerate 0.1% creamTopicalGeneric name | — | US FDA | Available on request |
| Betamethasone valerate 0.12% foamTopicalGeneric name | — | US FDA | Available on request |
| Betamethasone valerate 0.12% creamTopicalGeneric name | — | US FDA | Available on request |
| Betamethasone valerate 0.1% ointmentTopicalGeneric name | — | US FDA | Available on request |
| Betamethasone valerate 0.12% ointmentTopicalGeneric name | — | US FDA | Available on request |
| Betamethasone valerate 1 mg/mL lotionTopicalGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 2 September 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 6 presentations of Betamethasone valerate and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Betamethasone valerate on 2 September 1967, according to Drugs@FDA.
No listed presentation of Betamethasone valerate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.